Analyst Price Target is $11.00
▲ +1,656.63% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for Zynerba Pharmaceuticals in the last 3 months. The average price target is $11.00, with a high forecast of $11.00 and a low forecast of $11.00. The average price target represents a 1,656.63% upside from the last price of $0.63.
Current Consensus is
The current consensus among 3 polled investment analysts is to buy stock in Zynerba Pharmaceuticals. This Buy consensus rating has held steady for over two years.